Keiko Ishigaki

892 citations

58 papers · 476 indexed · h-index 13

Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders 7
Genetics
- Neurogenetic and Muscular Disorders Research 12
Cardiology and Cardiovascular Medicine
Neurology
- Myasthenia Gravis and Thymoma 7
- Parkinson's Disease Mechanisms and Treatments 4
Rheumatology
Molecular Biology
- Muscle Physiology and Disorders 27
- Mitochondrial Function and Pathology 13
Cellular and Molecular Neuroscience
- Genetic Neurodegenerative Diseases 11
Physiology
- Lysosomal Storage Disorders Research 5

Co-authors: Makiko Ōsawa Kayoko Saito Terumi Murakami Toshio Nakanishi Kenichi Okumura Hidemi Kajimoto Hirofumi Tomimatsu Makoto Nakazawa
Cited by: Clinical Biochemistry Genetics Cardiology and Cardiovascular Medicine
Journals: SHILAP Revista de lepidopterología (1 paper)Scientific Reports (2 papers)Acta Neuropathologica (1 paper)
Partner nations: Japan United States Iran

In The Last Decade

Keiko Ishigaki

50 papers receiving 458 citations

Peers

Countries citing papers authored by Keiko Ishigaki

Since Specialization

Citations

This map shows the geographic impact of Keiko Ishigaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Ishigaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Ishigaki more than expected).

Fields of papers citing papers by Keiko Ishigaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keiko Ishigaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Ishigaki. The network helps show where Keiko Ishigaki may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Keiko Ishigaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Keiko Ishigaki Line = papers co-authored together Keiko Ishigaki links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Spinal cord findings in a long-term survivor of Duchenne muscular dystrophy SHILAP Revista de lepidopterología ·Ruruka Imaizumi,Tomoko Yamamoto,Kenta Masui,Keiko Ishigaki,Takatoshi Sato,Terumi Murakami,Minobu Shichiji,K. Ishiguro,Atsushi Kurata	2024	0
2	Social difficulties and care burden of adult Duchenne muscular dystrophy in Japan: a questionnaire survey based on the Japanese Registry of Muscular Dystrophy (Remudy) Orphanet Journal of Rare Diseases ·Madoka Mori‐Yoshimura,Keiko Ishigaki,Yuko Shimizu‐Motohashi,Naoko Ishihara,Atushi Unuma,Sumiko Yoshida,Harumasa Nakamura	2024	0
3	Rare mosaic variant of GJA1 in a patient with a neurodevelopmental disorder Human Genome Variation ·Rina Shimomura,Tomoe Yanagishita,K. Ishiguro,Minobu Shichiji,Takatoshi Sato,Keiko Shimojima Yamamoto,Miho Nagata,Yasuki Ishihara,Yohei Miyashita,Keiko Ishigaki,Satoru Nagata,Yoshihiro Asano,Toshiyuki Yamamoto	2024	1
4	Urinary titin reflects the severity of walking ability, muscle strength, and muscle and cardiac damage in patients with Becker muscular dystrophy Clinica Chimica Acta ·Hiroyuki Awano,Yoshinori Nambu,Kayo Osawa,Taku Shirakawa,Tsuyoshi Matsumura,Akiko Wakisaka,Satoshi Kuru,Michinori Funato,Yasuhiro Takeshima,Keiko Ishigaki,Michio Kobayashi,Tatsuharu Sato,Tatsuya Fujii,Kazuma Sugie,Kôichi Kimura,Hirofumi Komaki,Akinori Nakamura,Masafumi Matsuo	2024	2
5	The Clinical Course and Treatment of a Case of Refractory Systemic Juvenile Myasthenia Gravis Successfully Treated with Thymectomy The Tohoku Journal of Experimental Medicine ·Moriei Shibuya,Minobu Shichiji,Miki Ikeda,Kaori Kodama,Takuya Miyabayashi,Ryo Sato,Yukimune Okubo,Wakaba Endo,Takehiko Inui,Noriko Togashi,Mika Nagao,Kaname Sato,Takatoshi Sato,Masato Kanzaki,Osamu Segawa,Kenta Masui,Keiko Ishigaki,Kazuhiro Haginoya	2023	0
6	In utero transplantation of myoblasts and adipose-derived mesenchymal stem cells to murine models of Duchenne muscular dystrophy does not lead to engraftment and frequently results in fetal death Regenerative Therapy ·Yuki Kihara,Yukie Tanaka,Masanari Ikeda,Jun Homma,Ryo Takagi,Keiko Ishigaki,Keitaro Yamanouchi,Hiroaki Honda,Satoru Nagata,Masayuki Yamato	2022	1
7	Potential patient screening for late-onset Pompe disease in suspected sleep apnea: a rationale and study design for a Prospective Multicenter Observational Cohort Study in Japan (PSSAP-J Study) Sleep And Breathing ·Motoo Yamauchi,Hideaki Nakayama,Satomi Shiota,Yasuyoshi Ohshima,Jiro Terada,Tsuguo Nishijima,Motomichi Kosuga,Takuro Kitamura,Naoko Tachibana,Takuya Oguri,Ryutaro Shirahama,Yasuhiro Aoki,Keiko Ishigaki,Kazuma Sugie,Tomoko Yagi,Hisae Muraki,Yukio Fujita,Tsunenori Takatani,Shigeo Muro	2020	1
8	Novel EXOSC9 variants cause pontocerebellar hypoplasia type 1D with spinal motor neuronopathy and cerebellar atrophy Journal of Human Genetics ·Masamune Sakamoto,Kazuhiro Iwama,Futoshi Sekiguchi,Hideaki Mashimo,Satoko Kumada,Keiko Ishigaki,Nobuhiko Okamoto,Mahdiyeh Behnam,Mohsen Ghadami,Eriko Koshimizu,Satoko Miyatake,Satomi Mitsuhashi,Takeshi Mizuguchi,Atsushi Takata,Hirotomo Saitsu,Noriko Miyake,Naomichi Matsumoto	2020	13
9	Infection-associated decrease of serum creatine kinase levels in Fukuyama congenital muscular dystrophy Brain and Development ·Saoko Takeshita,Yoshiaki Saito,Yoshitaka Oyama,Yoshihiro Watanabe,Azusa Ikeda,Mizue Iai,Takatoshi Sato,Keiko Ishigaki,Shuichi Ito	2020	1
10	Characteristic findings of skeletal muscle MRI in caveolinopathies Neuromuscular Disorders ·K. Ishiguro,Takahiro Nakayama,Masaru Yoshioka,Terumi Murakami,S. Kajino,Minobu Shichiji,Takatoshi Sato,Naomi Hino‐Fukuyo,Satoshi Kuru,Makiko Ōsawa,Satoru Nagata,Mariko Okubo,Nobuyuki Murakami,Yukiko Hayashi,Ichizo Nishino,Keiko Ishigaki	2018	6
11	Renal dysfunction is rare in Fukuyama congenital muscular dystrophy Brain and Development ·Keiko Ishigaki,Ikuko Kato,Terumi Murakami,Takatoshi Sato,Minobu Shichiji,K. Ishiguro,Kiyonobu Ishizuka,Makoto Funatsuka,Kayoko Saito,Makiko Ōsawa,Satoru Nagata	2018	5
12	National registry of patients with Fukuyama congenital muscular dystrophy in Japan Neuromuscular Disorders ·Keiko Ishigaki,C. Ihara,Harumasa Nakamura,Madoka Mori‐Yoshimura,Kazushi Maruo,Mariko Taniguchi‐Ikeda,En Kimura,Terumi Murakami,Takatoshi Sato,Tatsushi Toda,Hisanobu Kaiya,Makiko Ōsawa	2018	18
13	Congenital myasthenic syndrome in Japan: Ethnically unique mutations in muscle nicotinic acetylcholine receptor subunits Neuromuscular Disorders ·Yoshiteru Azuma,Tomohiko Nakata,Motoki Tanaka,Xin‐Ming Shen,Mikako Ito,Satoshi Iwata,Tatsuya Okuno,Yoshiko Nomura,N Ando,Keiko Ishigaki,Bisei Ohkawara,Akio Masuda,Jun Natsume,Seiji Kojima,Masahiro Sokabe,Kinji Ohno	2014	19
14	Congenital fiber type disproportion myopathy caused by LMNA mutations Journal of the Neurological Sciences ·S. Kajino,Kayo Ishihara,Kanako Goto,Keiko Ishigaki,S. Noguchi,Ikuya Nonaka,Makiko Ōsawa,Ichizo Nishino,Yukiko Hayashi	2014	12
15	Close monitoring of initial enzyme replacement therapy in a patient with childhood-onset Pompe disease Brain and Development ·Keiko Ishigaki,Terumi Murakami,Toshio Nakanishi,Eri Oda,Takatoshi Sato,Makiko Ōsawa	2011	9
16	Severe muscle damage following viral infection in patients with Fukuyama congenital muscular dystrophy Brain and Development ·Terumi Murakami,Keiko Ishigaki,Seigo Shirakawa,Harumi Ikenaka,Masako Sakauchi,Makiko Ōsawa	2011	12
17	Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: From our experience of 4 cases including an autopsy case Molecular Genetics and Metabolism ·Hiroshi Kobayashi,Yohta Shimada,Masahiro Ikegami,Toshinao Kawai,Ken Sakurai,Takashi Urashima,Masatoshi Ijima,Masako Fujiwara,Eiko Kaneshiro,Toya Ohashi,Yoshikatsu Eto,Keiko Ishigaki,Makiko Ōsawa,Sandra Obikawa Kyosen,Hiroyuki Ida	2010	42
18	Benefits of FK 506 for refractory eye symptoms in a young child with ocular myasthenia gravis Brain and Development ·Keiko Ishigaki,Keiko Shishikura,Terumi Murakami,Haruko Suzuki,Yoshito Hirayama,Makiko Ōsawa	2008	14
19	TRH therapy in a patient with juvenile Alexander disease Brain and Development ·Keiko Ishigaki,Yasushi Ito,Yukio Sawaishi,K. Kodaira,Makoto Funatsuka,Nozomi Hattori,Kazutoshi Nakano,Kayoko Saito,Makiko Ōsawa	2006	8
20	Two novel mutations in the COLQ gene cause endplate acetylcholinesterase deficiency Neuromuscular Disorders ·Keiko Ishigaki,Delphine Nicolle,Éric Krejci,(unknown),Jeanine Koenig,(unknown),B. Eymard,Daniel Hantaı̈	2003	28

About Keiko Ishigaki

Keiko Ishigaki is a scholar working on Genetics, Clinical Biochemistry and Neurology, having authored 58 papers that have together received 476 indexed citations. Recurring topics across this work include Muscle Physiology and Disorders (27 papers), Mitochondrial Function and Pathology (13 papers), Neurogenetic and Muscular Disorders Research (12 papers), Genetic Neurodegenerative Diseases (11 papers), Metabolism and Genetic Disorders (7 papers), Myasthenia Gravis and Thymoma (7 papers), Lysosomal Storage Disorders Research (5 papers) and Parkinson's Disease Mechanisms and Treatments (4 papers). The work is most often cited by research in Clinical Biochemistry (46 citations), Genetics (50 citations) and Cardiology and Cardiovascular Medicine (107 citations). Keiko Ishigaki has collaborated with scholars based in Japan, United States and Iran. Frequent co-authors include Makiko Ōsawa, Kayoko Saito, Terumi Murakami, Toshio Nakanishi, Kenichi Okumura, Hidemi Kajimoto, Hirofumi Tomimatsu, Makoto Nakazawa, Takatoshi Sato and Yasushi Ito. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Acta Neuropathologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact